Supporting the Patient Care Team for Improving Outcomes Resources and efficacy studies of the Vasc-Alert solution

Vasc-Alert News

Understand the Value of Vascular Access Surveillance

Understand the Value of Vascular Access Surveillance in Dialysis in Value-Based Care

Value-based care (VBC) is a healthcare delivery model that rewards providers for improving patient outcomes while reducing costs. In the context of dialysis, VBC programs typically focus on increasing the use of arteriovenous fistulas (AVFs), which are the preferred vascular access for hemodialysis. AVFs have the longest patency and are associated with the lowest risk of complications.

Vascular access surveillance is the process of monitoring vascular accesses for signs of dysfunction or complications. This is important for all dialysis patients, but it is especially important for those with AVFs. Early detection and treatment of vascular access problems can help to prolong AVF patency and prevent serious complications, such as thrombosis and infection.

There is a strong body of evidence supporting the value of vascular access surveillance in dialysis. For example, a study published in the Journal of the American Society of Nephrology found that patients who received regular vascular access surveillance had a 25% lower risk of AVF thrombosis than those who did not.

Vascular access surveillance is also valuable in the context of VBC because it can help to reduce healthcare costs. By preventing vascular access complications, vascular access surveillance can help to reduce the need for hospitalization, surgery, and other expensive interventions.

In addition to the financial benefits, vascular access surveillance can also improve patient quality of life. Patients with well-functioning vascular accesses are less likely to experience symptoms such as pain, swelling, and infection. They are also more likely to be able to adhere to their dialysis schedule and achieve their target dialysis dose.

Overall, vascular access surveillance is an essential component of high-quality dialysis care and is particularly valuable in the context of VBC.

Here are some specific examples of how vascular access surveillance can improve value-based care in dialysis:

  • Reduced risk of AVF thrombosis, which is a major cause of hospitalization and mortality in dialysis patients.
  • Improved AVF patency, which can lead to more efficient dialysis treatments and better patient outcomes.
  • Reduced need for surgery and other expensive interventions to treat vascular access complications.
  • Improved patient quality of life and adherence to dialysis therapy.

By investing in vascular access surveillance, VBC programs can improve patient outcomes and reduce costs over the long term.